Amebiasis
Anthrax
Arboviral infection
Babesiosis
Botulism
Brucellosis
Campylobacteriosis
Chancroid
Chlamydia trachomatis infection
Cholera
Cryptosporidiosis
Cyclosporiasis
Diphtheria
E. coli 0157:H7 infections
Ehrlichiosis
Encephalitis
Giardiasis
Glanders
Gonococcal infection
Group A Streptococcal invasive disease
Group B Streptococcal invasive disease
Hantavirus disease
Hemolytic uremic syndrome
Hemophilus influenzae (invasive disease)
Hepatitis (A; B; C)
Herpes infection in infants aged 60 days or younger (neonatal)
Hospital-associated infections (as defined in section 2.2 of this Part)
Influenza (laboratory-confirmed)
Legionellosis
Listeriosis
Lyme disease
Lymphogranuloma venereum
Malaria
Measles
Melioidosis
Meningitis
Mpox
Aseptic
Hemophilus
Meningococcal
Other (specify type) Meningococcemia Monkeypox Mumps
Pertussis (whooping cough) Plague Poliomyelitis Psittacosis Q Fever Rabies
Rocky Mountain spotted fever Rubella
Rabies
Respiratory syncytial virus (RSV) (laboratory confirmed cases of RSV or deaths caused by laboratory confirmed RSV in persons younger than 18 years)
Rocky Mountain spotted fever
Congenital rubella syndrome
Salmonellosis
Severe or novel coronavirus
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), including Pediatric Multi-system Inflammatory Syndrome, or any other complication suspected of being associated with SARS-CoV-2 infection
Severe Acute Respiratory Syndrome (SARS)
Middle East Respiratory Syndrome (MERS)
Other (specify type) Shigellosis Smallpox
Staphylococcal enterotoxin B poisoning Streptococcus pneumoniae invasive disease Syphilis, specify stage Tetanus
Typhoid
Varicella (not zoster/shingles)
Vaccinia disease: (as defined in Section 2.2 of this Part)
Toxic Shock Syndrome Trichinosis
Tuberculosis, current disease (specify site) Tularemia Typhoid
Vaccinia disease (as defined in section 2.2 of this Part) Viral hemorrhagic fever
Yersiniosis
N.Y. Comp. Codes R. & Regs. Tit. 10 § 2.1